Humana Reports First Quarter 2021 Financial Results; Reaffirms Full Year 2021 Adjusted EPS Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Humana (HUM) PT Raised to $505 at Cantor Fitzgerald Following Earnings
April 28, 2021 11:13 AM EDTCantor Fitzgerald analyst Steven Halper raised the price target on Humana (NYSE: HUM) to $505.00 (from $450.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our Overweight rating on HUM shares and increase our price target to $505 from $450. This morning, April 28, the company... More
Humana (HUM) Tops Q1 EPS by 60c, Maintains FY EPS Guidance
April 28, 2021 6:33 AM EDTHumana (NYSE: HUM) reported Q1 EPS of $7.67, $0.60 better than the analyst estimate of $7.07. Revenue for the quarter came in at $20.67 billion versus the consensus estimate of $20.52 billion.
GUIDANCE:
Humana sees FY2021 EPS of $21.25-$21.75, versus the consensus of $21.54.
For earnings history and earnings-related data on Humana (HUM) click here.
... More